Home
½ÃÀÛÆäÀÌÁö
Áö³È£º¸±â
·Î±×ÀÎ
ȸ¿ø°¡ÀÔ
±¸µ¶½Åû
Àüü±â»ç
2024-03-29 ±Ý 19:55
±â»ç°Ë»ö
Cover Story
¼øȯ±â
³»ºÐºñ
È£Èí±â
¼Òȱâ
½Å°æ°ú
Á¤½Å°Ç°
°¨¿°³»°ú
Sub Story
Interview
Drug Review
Conference Report
Late Breaking Studies
Expert Opinion
Primary Expert Opinion
The Rare Disease
ÇмúÀÚ¹®À§¿ø
RTM
»ó´Ü¿©¹é
񃯇
(Àüü 1,637°Ç)
Á¦¸ñº¸±â
Á¦¸ñº¸±â
Á¦¸ñ+³»¿ë
[Sub Story]
º¹ÇÕ ÀÌ»óÁöÁúÇ÷Áõ ¸¶¹ýÀÇ ÅºÈ¯Àº LDL¡¤TG¡¤HDL µ¿½ÃÁ¶Àý
Magic Bullet½É±Ù°æ»öÁõ º´·ÂÀÚ µî ½ÉÇ÷°üÁúȯ °íÀ§Ç豺ÀÎ ÀÌ»óÁöÁúÇ÷Áõ ȯÀÚ¿¡¼ Ä¡·á 1Â÷Ÿ±êÀÌ LDL ÄÝ·¹½ºÅ×·Ñ(LDL-C) Á¶ÀýÀ̶ó´Â °ÍÀº ÁÖÁöÀÇ »ç½ÇÀÌ´Ù. LDL ÄÝ·¹½ºÅ×·Ñ Á¶Àý±âÀüÀÇ ½ºÅ¸Æ¾ÀÌ ÀÌ»óÁöÁúÇ÷Áõ...
ÀÌ»óµ· ±âÀÚ
|
2018-09-04 15:38
¶óÀÎ
[Sub Story]
ÁöÁúÀÎÀÚ °ãÄ¡¸é ½ºÅ¸Æ¾À¸·Îµµ ¿ªºÎÁ·
½ºÅ¸Æ¾½ºÅ¸Æ¾Àº LDL ÄÝ·¹½ºÅ×·Ñ Á¶ÀýÀÌ ÁÖ±âÀüÀÌ´Ù. °æ¿ì¿¡ µû¶ó HDL ÄÝ·¹½ºÅ×·ÑÀ» Á¶ÀýÇÑ´Ù´Â º¸°í°¡ ÀÖ±â´Â ÇÏÁö¸¸, Áß¼ºÁö¹æ µî ´Ù¾ç...
ÀÌ»óµ· ±âÀÚ
|
2018-09-04 15:35
¶óÀÎ
[Sub Story]
HDL-C ¾à¹° ÇöÁÖ¼Ò´Â?
CETP ¾ïÁ¦Á¦HDL ÄÝ·¹½ºÅ×·ÑÀ» ³ôÀÌ´Â Àü·«À¸·Î ÁÖ¸ñ¹ÞÀº ¶Ç ´Ù¸¥ ¾àÁ¦´Â ÄÝ·¹½ºÅ×·Ñ ¿¡½ºÅ׸£ ÀüÀ̴ܹéÁú(CETP) ¾ïÁ¦Á¦°¡ ´ëÇ¥ÀûÀÌ´Ù...
ÀÌ»óµ· ±âÀÚ
|
2018-09-04 15:31
¶óÀÎ
[Sub Story]
CCB/ARB/½ºÅ¸Æ¾ º¹ÇÕÁ¦ ¾ÈÁ¤Àû ¡®ASCVD °ü¸®¡¯ ÀüȯÁ¡
ÅëÇÕÀû CVD À§ÇèÀÎÀÚ °ü¸®ÀÌ»óÁöÁúÇ÷Áõ°ú °íÇ÷¾Ð °ü¸®ÀÇ ±Ã±ØÀûÀÎ ¸ñÀûÀº ½ÉÇ÷°ü»ç°Ç ¿¹¹æ ¹× ½ÉÇ÷°ü »ç¸Á °¨¼Ò´Ù. À̸¦ À§ÇØ Çаè´Â ½ÉÇ÷...
ÀÓ¼¼Çü ±âÀÚ
|
2018-09-04 15:28
¶óÀÎ
[Sub Story]
ÁöÁúÄ¡·áÁ¦°¡ Ç÷´ç°ÇÏÁ¦¸¦ ¸¸³ª¸é¡¦
¸ÞÆ®Æ÷¸£¹Î¸ÕÀú ³íÀǵǴ ¾à¹°Àº ¸ÞÆ®Æ÷¸£¹ÎÀÌ´Ù. ¸ÞÆ®Æ÷¸£¹ÎÀº °¡Àå ¿À·¡µÇ°í È¿°úÀûÀÎ ´ç´¢º´ ¾à¹°·Î ¼Õ²ÅÈ÷°íÀÖ´Ù. ¸ÞÆ®Æ÷¸£¹ÎÀº UKPDS ...
ÀÓ¼¼Çü ±âÀÚ
|
2018-09-04 15:17
¶óÀÎ
[Sub Story]
½ºÅ¸Æ¾°ú Ç×°íÇ÷¾ÐÁ¦ ½ÉÇ÷°üÁúȯ ¸Â¼³ ´ÜÀÏÆÀ ²Ù¸°´Ù
°íÇ÷¾Ð¡®Ä§¹¬ÀÇ »ìÀÎÀÚ¡¯·Î ºÒ¸®´Â °íÇ÷¾ÐÀÇ À¯º´Æ¯¼º Áß Çϳª´Â ³ôÀº Ç÷¾Ð¿¡ ´õÇØ ÀÌ»óÁöÁúÇ÷Áõ¡¤°íÇ÷´ç¡¤ºñ¸¸ µî ´ë»çÁúȯÀ» µ¿¹ÝÇÏ´Â »ç·Ê°¡ ...
ÀÌ»óµ· ±âÀÚ
|
2018-09-04 15:13
¶óÀÎ
[Drug Review]
·Î¼ö¹Ù½ºÅ¸Æ¾/¹ß»ç¸£Åº º¹ÇÕÁ¦, ȯÀÚƯ¼º µû¶ó ¸ÂÃãÄ¡·á °¡´É
·Î¹ÙƼźÀº ÀÌ»óÁöÁúÇ÷ÁõÄ¡·áÁ¦ ·Î¼ö¹Ù½ºÅ¸Æ¾°ú ARB °è¿ Ç×°íÇ÷¾ÐÁ¦ ¹ß»ç¸£ÅºÀ» ÇϳªÀÇ Á¤Á¦¿¡ ´ãÀº º¹ÇÕÁ¦·Î¼, °íÇ÷¾Ð°ú ÀÌ»óÁöÁúÇ÷ÁõÀ» µ¿...
ÀÌ»óµ· ±âÀÚ
|
2018-09-04 15:11
¶óÀÎ
[Conference Report]
PCSK9 ¾ïÁ¦Á¦, Lp(a) ³ôÀ»¼ö·Ï È¿°ú Å©´Ù
FOURIER Ãß°¡ºÐ¼®¿¡º¼·ÎÄí¸¿ ÁÖ¿äÀÓ»óÀÎ FOURIER ¿¬±¸ÀÇ »õ·Î¿î ºÐ¼®¿¡¼´Â Lp(a)°¡ ³ôÀº ȯÀÚ¿¡¼ Lp(a) ¼öÄ¡°¡ ³·Àº ȯ...
ÀÓ¼¼Çü ±âÀÚ
|
2018-09-04 15:09
¶óÀÎ
[Conference Report]
Lp(a)¡¤¿°Áõµµ Á׻󵿸ưæÈÁõ ÀÓ»óÀû Ÿ±ê
ÀÓ»óÀû ÇýÅÃÀ» ±â´ëÇϱâ À§ÇÑ Lp(a) ¼öÄ¡PCSK9 ¾ïÁ¦Á¦ ¿¬±¸¿¡¼ Á¦½ÃµÈ Lp(a)ÀÇ ÀÓ»óÀû À¯¿ë¼ºÀ» Æò°¡ÇÑ º°µµÀÇ ¿¬±¸µµ ¹ßÇ¥µÆ´Ù...
ÀÓ¼¼Çü ±âÀÚ
|
2018-09-04 15:07
¶óÀÎ
[Conference Report]
½ºÅÙÆ®Ç÷ÀüÁõ¡¤¿°Áõ¡¤È¯°æÀÎÀÚ °³¼±ÅëÇÑ Á׻󵿸ưæÈÁõ °ü¸®
Á׻󵿸ưæÈÁõ ¹ß»ý ¿øÀμ¼¼Ç¿¡¼ ¿¬ÀÚ·Î ³ª¼± ¹Ì±¹ Á¶ÁöŸ¿î´ëÇÐ Renu Virmani ±³¼ö´Â »õ·Î¿î ÇüÅÂÀÇ Á·»óµ¿¸Æ°æÈÁõÀ¸·Î Àνĵǰí ...
ÀÓ¼¼Çü ±âÀÚ
|
2018-09-04 14:47
¶óÀÎ
[Deep in Guideline]
ÀÌ»óÁöÁúÇ÷Áõ Ä¡·áÁöħ 2018³âÆÇ ¡®½Ã»çȸ¡¯ °¡´Ù
ÀÌ»óÁöÁúÇ÷Áõ Ä¡·áÀü·«ÀÇ º¯È°¡ ±Þ¹°»ìÀ» Ÿ¸é¼ ±¹³» Çа赵 ¹ßÀ» ¸ÂÃè´Ù. Çѱ¹ÁöÁú‧µ¿¸Æ°æÈÇÐȸ´Â 2015³â ÀÌ»óÁöÁúÇ÷Áõ Ä¡·á...
¹Ú¼±Çý
|
2018-09-04 14:39
¶óÀÎ
[Deep in Guideline]
°íÇ÷¾Ð °¡À̵å¶óÀÎ ÃáÃßÀü±¹½Ã´ë
¹Ì±¹Àº ³ôÀÌ°í Çѱ¹¡¤À¯·´Àº À¯ÁöÇÏ°í°¡Àå ÁÖ¸ñÇØ¾ß ÇÒ ±Ç°í¾ÈÀº °íÇ÷¾Ð Áø´Ü±âÁØÀÌ´Ù. ±âÁØ¿¡ µû¶ó °íÇ÷¾Ð À¯º´·üÀÌ ´Þ¶óÁö¸ç, ÀÌ·¸°Ô µÉ °æ...
¹Ú¼±Çý ±âÀÚ
|
2018-09-04 14:17
¶óÀÎ
[Cover Story]
´ëÇѹα¹ÀÌ Á÷¸éÇÑ ´ç´¢º´ 4´ë³Á¦
Fact Sheet in Korea´ëÇѹα¹ÀÌ Á÷¸éÇÑ ´ç´¢º´ °ü·Ã °úÁ¦µéÀ» È¿À²ÀûÀ¸·Î ±Øº¹ÇÒ ¼ö ÀÖ´À³Ä¿¡ µû¶ó ´ç´¢º´ ´ë¶õÀÇ Çö½ÇÈ°¡ Á¡...
ÀÌ»óµ· ±âÀÚ
|
2018-08-01 15:37
¶óÀÎ
[Sub Story]
¾à¹°Ä¡·á ¾ç¡¤Áú ¼ºÀå¿¡µµ Á¶Àý·ü ¸ø¿Ã·Á
º´¿ëó¹æ 74%´ç´¢º´ÇÐȸ º¸°í¼ÀÇ ´ç´¢º´Ä¡·áÁ¦ ó¹æºÐ¼® °á°ú¸¦ º¸¸é, Ç÷´ç°ÇÏÁ¦ ó¹æÀÇ °µµ°¡ Áõ°¡ÇÏ°í ÀÖÀ½À» ¿³º¼ ¼ö ÀÖ´Ù. 2016...
ÀÌ»óµ· ±âÀÚ
|
2018-08-01 15:17
¶óÀÎ
[Sub Story]
DPP-4 ¾ïÁ¦Á¦ ó¹æ ±ÞÁõ µ¿°è¿ ³» ½ºÀ§Äª Àü·«¿¡ ÁÖ¸ñ
¾à¹°Ä¡·á Æз¯´ÙÀÓ ÀüȯÁö³ ¼ö½Ê³â°£ Á¦2Çü ´ç´¢º´ ¾à¹°Ä¡·á´Â ¸¹Àº ±â¼ú¹ßÀüÀ» ÀÌ·ï ¿Ô´Ù. ¸ÞÆ®Æ÷¸£¹Î, ¼³Æù¿ä¼ÒÁ¦, Àν¶¸° µî¿¡ À̾î Ƽ...
ÀÌ»óµ· ±âÀÚ
|
2018-08-01 15:10
¶óÀÎ
[Sub Story]
¡°È¿´É¡¤ÀúÇ÷´ç¡¤Ã¼Áß¡¤ÇÕº´Áõ °í·ÁÇØ ¾àÁ¦¼±Åá±
¾Ë°í¸®µë¾à¹°Ä¡·áÀÇ ¿øÄ¢Àº ¾Ë°í¸®µë¿¡ ¸ðµÎ ³ì¾Æ ÀÖ´Ù. ¾Ë°í¸®µë°ú ÀÌÇÏ ºÎ¿¬¼³¸í¿¡ µû¸£¸é, ´çÈÇ÷»ö¼Ò(A1C) ¸ñÇ¥´Â 6.5% ¹Ì¸¸À¸·Î ...
ÀÌ»óµ· ±âÀÚ
|
2018-08-01 14:50
¶óÀÎ
[Sub Story]
¿¥Æı۸®Ç÷ÎÁø, ¿©·¯ µ¿¹ÝÁúȯ¿¡¼ ½ÉÇ÷°ü ÀÓ»óÇýÅà º¸°í
E-LIFT & NAFLD¿¥Æı۸®Ç÷ÎÁøÀº ÃÖ±Ù ¹Ì±¹´ç´¢º´ÇÐȸ Àú³Î Diabetes Care 2018¿¡ °ÔÀçµÈ Àӻ󿬱¸(E-LIFT)¿¡¼...
ÀÌ»óµ· ±âÀÚ
|
2018-08-01 14:07
¶óÀÎ
[Sub Story]
Çѱ¹ÀÎ ¸®¾ó¿ùµå¿¡¼ DPP-4 ¾ïÁ¦Á¦ ºÃ´õ´Ï¡¦
DPP-4 ¾ïÁ¦Á¦DPP-4 ¾ïÁ¦Á¦´Â ÀÎÅ©·¹Æ¾À» ºñÈ°¼ºÈÇÏ´Â DPP-4 È¿¼Ò¸¦ ¾ïÁ¦ÇØ GLP-1ÀÇ »ýÈ°¼ºÈ¸¦ ÃËÁøÇÏ´Â ±âÀüÀÌ´Ù. ü³» Ç÷...
ÀÌ»óµ· ±âÀÚ
|
2018-08-01 13:45
¶óÀÎ
[Sub Story]
SGLT-2 ¾ïÁ¦Á¦ ±¤¹üÀ§ ½ÉÇ÷°ü ÇýÅà ȮÀÎ
Asia focus trial¿¬±¸ÆÀÀº CVD-REAL 2 ¿¬±¸ÀÇ ÁÖ¿ä ¹è°æÀ¸·Î SGLT-2 ¾ïÁ¦Á¦ ½ÉÇ÷°ü ÇýÅÃÀÇ ¹üÀ§È®ÀåÀ» ²Å¾Ò´Ù. ¿¬±¸ÆÀÀº ¡°¿¥Æı۸®Ç÷ÎÁøÀÇ EMPA-REG OUTCOME, Ä«³ª±Û¸®Ç÷ÎÁøÀÇ CANV...
ÀÓ¼¼Çü ±âÀÚ
|
2018-08-01 13:33
¶óÀÎ
[Drug Review]
¾Æ³ª±Û¸³Æ¾ ƯÀåÁ¡¿¡ ÀÓ»óÀÇµé ¡°Ã³¹æ ±àÁ¤¡± ÀÀ´ä
Ç÷´çÁ¶Àý¸Þµð°ÔÀÌÆ®´Â ÃÖ±Ù Àü±¹ ÁÖ¿äµµ½ÃÀÇ Á¾ÇÕº´¿ø Àü¹®ÀÇ(171¸í)¿Í °³¿ø°¡ ³»°ú, ÀϹÝÀÇ(150¸í) ´ë»óÀ¸·Î Ç÷´ç°ÇÏÁ¦ ÀÎÁöµµ¿¡ ´ëÇÑ...
ÀÌ»óµ· ±âÀÚ
|
2018-08-01 13:29
-
ÀÌÀü
81
82
-
¿©¹é
Sub
news
¡°ACEI ÀÓ»ó±Ù°Å ³õ°í, ȯÀÚ ¼³µæÇÏÀÚ¡±
Q. Ç÷¾Ð°ÇÏ Ãø¸é¿¡¼ ACEIÀÇ Æ¯¼ºÀº?ù...
¡°SGLT-2i Ȳ±Ý±â´Â TZD¿Í º´¿ëÀ¸·ÎºÎÅÍ¡±
Q. SGLT-2iÀÇ °è¿È¿°ú¿¡ ´ëÇÑ °ßÇØ´Â...
¡°°í°µµ ½ºÅ¸Æ¾ Á¦Á¦ È¿°ú ´ëµîÇϳª ¾ÈÀü¼º ´Ù¸¦ ¼öµµ¡±
Q. CAD ȯÀÚÀÇ ÀÌ»óÁöÁúÇ÷Áõ Ä¡·áÀü·«Àº?...
¿©¹é
¿©¹é
Back to Top